MENU
+Compare
KZR
Stock ticker: NASDAQ
AS OF
Feb 3 closing price
Price
$6.10
Change
+$1.70 (+38.64%)
Capitalization
44.6M

KZR Kezar Life Sciences Inc Forecast, Technical & Fundamental Analysis

Kezar Life Sciences Inc is a clinical-stage biotechnology company... Show more

Industry: #Biotechnology
KZR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for KZR with price predictions
Feb 02, 2026

KZR's Stochastic Oscillator is sitting in oversold zone for 1 day

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KZR advanced for three days, in of 260 cases, the price rose further within the following month. The odds of a continued upward trend are .

KZR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 56 cases where KZR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for KZR moved out of overbought territory on January 09, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on January 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KZR as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

KZR moved below its 50-day moving average on January 09, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for KZR crossed bearishly below the 50-day moving average on January 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KZR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.537) is normal, around the industry mean (27.778). P/E Ratio (0.000) is within average values for comparable stocks, (51.342). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.892). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (7.752) is also within normal values, averaging (333.006).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KZR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KZR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
KZR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of therapies targeting protein homeostasis

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4000 Shoreline Court
Phone
+1 650 822-5600
Employees
58
Web
https://www.kezarlifesciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLCMF3.00N/A
N/A
Sinch AB
FNCJF0.09N/A
N/A
Fancamp Exploration Ltd.
LPKFF9.62N/A
N/A
Lpkf Laser & Electronics AG
GRWTF14.82N/A
N/A
Great West Lifeco, Inc.
BPHLF1.68N/A
N/A
Bank of the Philippine Islands

KZR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KZR has been loosely correlated with AMRN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if KZR jumps, then AMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KZR
1D Price
Change %
KZR100%
+0.82%
AMRN - KZR
56%
Loosely correlated
+0.50%
RANI - KZR
55%
Loosely correlated
-0.83%
IRON - KZR
49%
Loosely correlated
+4.31%
CNTB - KZR
47%
Loosely correlated
+2.50%
ARTV - KZR
43%
Loosely correlated
+7.46%
More